Exploring gut immunity's role in neurologic diseases
Official title: Intestinal Immunity in Neurologic Disease
Run by Yale University · NCT06329453 · Data updated 2026-11-12
This study is trying to see how immune cells in the gut might affect diseases like Multiple Sclerosis and Parkinson's by looking at tissue samples from people having a colonoscopy.
Quick facts
| Study type | Observational |
|---|---|
| Ages | 18 Years to 99 Years |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | Yale University Academic / other |
| Drugs / interventions | prednisone |
| Locations | 1 site (North Haven, Connecticut) |
| Status | Recruiting |
| Started | August 2, 2022 |
| Main results expected | August 31, 2027 |
| Study ends | August 31, 2027 |
| Registry record updated | May 27, 2026 |
| Trial ID | NCT06329453 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates include individuals aged 18 and older who are undergoing a colonoscopy as part of standard care or are willing to participate in a research colonoscopy.
✕Probably not a fit
Patients with chronic inflammatory gastrointestinal diseases or those currently pregnant will not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This observational study aims to investigate the functional profiles of immune cells in the gastrointestinal tract and their contribution to autoimmune and neurologic diseases such as Multiple Sclerosis and Parkinson's Disease. Participants undergoing colonoscopy will provide tissue biopsies from the gastrointestinal mucosa, allowing researchers to analyze immune cell interactions in detail using modern single-cell technologies. The study seeks to uncover the relationship between gut immunity and neurologic disease pathogenesis, potentially shifting current paradigms in understanding these conditions.
Why it matters
Potential benefit: If successful, this study could lead to new insights into the role of gut immunity in neurologic diseases, potentially informing future therapeutic strategies.
How similar studies have gone: While the specific approach of this study is novel, previous research has indicated the importance of gut microbiome and immunity in neurologic diseases, suggesting potential for success.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Age 18 and up ONE of the following: * Recommended to under a screening colonoscopy (+/- upper endoscopy) as part of standard of care. This includes healthy individuals as well as those with neurologic and/or autoimmune diseases. OR * Willing to undergo research colonoscopy (+/- upper endoscopy) for research Exclusion Criteria: * Currently pregnant. Women of childbearing potential would perform a point of care urine pregnancy test prior to colonoscopy/endoscopy. * Known or suspected, chronic inflammatory gastrointestinal disease (e.g. inflammatory bowel disease) * Known, acute or chronic infections * Systemic antibiotic (PO or IV) use within 3 months of colonoscopy * Systemic corticosteroid use (equivalent of prednisone 10 mg per day or higher for \>5 days) within 2 weeks of colonoscopy * Malignancy, diagnosed or treated within the last 5 years * Probiotic use within 2 weeks of procedure * History of major GI surgery (e.g. colon resection, gastric bypass) * Bleeding disorder, or on anticoagulant medication * Other medical condition that, in the judgement of the investigator, would lead to higher-than-expected risks of biopsy * Allergy to MAC anesthesia or other drugs used pursuant to standard of care for biospecimen collection
Where it's running
-
Yale MS Clinic
North Haven, Connecticut, United States Recruiting
Study contacts
- Principal investigator: Erin Longbrake — Yale University
- Study coordinator: Cynthia Marques
- Email: cynthia.marques@yale.edu
- Phone: 2032876100
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Gut methane and Parkinson's: measuring if a probiotic helps people with Parkinson's, REM sleep behavior disorder, or cognitive concerns
This study tests whether a probiotic containing Limosilactobacillus reuteri can help people with Parkinson's disease, those at high risk for PD, and related cognitive issues by potentially improving gut methane levels and overall symptoms.
-
OCT in Neurological Practice: Use of Retinal Layers to Help Diagnose and Follow Neurological Diseases
This study tests whether optical coherence tomography (OCT) of the retina can help in diagnosing and tracking multiple sclerosis, Alzheimer's, Parkinson's, migraines, and other headaches compared with healthy people.
-
Early detection of neuropathologies affecting drivers
This project tests whether simple clinical and motor/cognitive tests can spot early signs of multiple sclerosis or Parkinson's disease that affect people who drive.
-
Using ultra-high field and metabolic MRI to understand resilience and degeneration in the aging and diseased brain
This project will try advanced 3T and 7T MRI scans, including sodium and phosphorus imaging, to see if metabolic and connectivity changes explain resilience and degeneration in adults with MS, NMOSD, MOGAD, Alzheimer’s, Parkinson’s, or healthy aging.
-
Motor learning with physical activity and advanced devices in healthy people and movement disorders
This study tests whether combining traditional physical activity with advanced devices and immersive therapy helps improve motor skills and functional recovery in healthy individuals and people with movement disorders.
-
Telehealth rehabilitation for neurodegenerative diseases
This study is testing if online rehabilitation programs can help people with Parkinson's Disease and Multiple Sclerosis feel better compared to traditional education methods.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.